These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23614890)

  • 1. Response to re: are the national orthopaedic thromboprophylaxis guidelines appropriate?
    Mirkazemi C; Bereznicki LR; Peterson GM
    ANZ J Surg; 2013 May; 83(5):395-6. PubMed ID: 23614890
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Are the national orthopaedic thromboprophylaxis guidelines appropriate?
    Owen J
    ANZ J Surg; 2013 May; 83(5):395. PubMed ID: 23614889
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the national orthopaedic thromboprophylaxis guidelines appropriate?
    Mirkazemi C; Bereznicki LR; Peterson GM
    ANZ J Surg; 2012 Dec; 82(12):913-7. PubMed ID: 22989056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients.
    Wells PS; Borah BJ; Sengupta N; Supina D; McDonald HP; Kwong LM
    Am J Manag Care; 2010 Nov; 16(11):857-63. PubMed ID: 21348557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism debate in joint arthroplasty.
    Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
    J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
    Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
    Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons.
    Anderson FA; Huang W; Friedman RJ; Kwong LM; Lieberman JR; Pellegrini VD;
    J Arthroplasty; 2012 May; 27(5):659-66.e5. PubMed ID: 22035977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
    Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
    Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can we reduce disagreement among guidelines for venous thromboembolism prevention?
    Sobieraj-Teague M; Eikelboom JW; Hirsh J
    J Thromb Haemost; 2010 Apr; 8(4):675-7. PubMed ID: 20096000
    [No Abstract]   [Full Text] [Related]  

  • 10. Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice.
    Lieberman JR; Heckmann N
    J Am Acad Orthop Surg; 2017 Dec; 25(12):789-798. PubMed ID: 29176502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unanswered questions, unmet needs in venous thromboprophylaxis.
    Cushner FD; Nett MP
    Orthopedics; 2009 Dec; 32(12 Suppl):62-6. PubMed ID: 20201478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies of thrombophylaxis following knee arthroplasty surgery.
    Campbell D; Smith P; Lewis P; Bruce W
    ANZ J Surg; 2010 Jun; 80(6):391-5. PubMed ID: 20618189
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    An VV; Phan K; Levy YD; Bruce WJ
    J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the utility of venous thrombosis prophylaxis in orthopedic surgery patients.
    Carrier M; Cushman M
    Ann Intern Med; 2012 May; 156(10):748-9. PubMed ID: 22412037
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivaroxaban for thromboprophylaxis after hip or knee replacement surgery.
    Belavic JM
    Nurse Pract; 2012 May; 37(5):6-8. PubMed ID: 22543875
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution.
    Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J
    J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
    Mrozik D; Jackiewicz A; Krzemiński M
    Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin should not be used for thromboprohylaxis in elective major orthopaedic surgery: a Croatian perspective.
    Kolundžić R; Šimić Jovičić M; Ðinkić M; Petrović T; Crnković T; Trkulja V
    Med Glas (Zenica); 2017 Aug; 14(2):244-249. PubMed ID: 28698538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty.
    Lachiewicz PF
    Instr Course Lect; 2011; 60():301-7. PubMed ID: 21553782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.